newsfilter
← Latest News
GlobeNewswire·

Athenex to Provide Corporate and Financial Update for the Third Quarter 2022 on November 3, 2022

BUFFALO, N.Y., Oct. 24, 2022 (GLOBE NEWSWIRE) -- Athenex (NASDAQ:ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer